We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

The ARANOTE trial enrolled adults 18 or older with confirmed metastatic prostate adenocarcinoma based on imaging and pathology. Participants had to have an ECOG performance status between 0 and 2 and ...

WHIPPANY, N.J., May 28, 2025--ASCO 2025: XOFIGO® Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases ...

Joe Biden's prostate cancer diagnosis reveals a high Gleason score, indicating aggressive cancer. Dr. Arpeet Shah and Dr. Nicole Saphier comment on what this means for prognosis.

In Biden’s case, the cancer has already metastasized – or spread – beyond the prostate, to the bones. This places him in stage four, the most advanced stage of prostate cancer.

The former president’s prostate cancer is characterized by a Gleason score of 9 and Grade Group 5 with bone metastasis, indicating that it is “pretty far advanced,” Fox News senior medical ...

Former US President Joe Biden, aged 82, has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, marking a serious escalation in the disease.

If your prostate cancer hasn't spread beyond your bones, your doctor may consider using the drug radium-223 (Xofigo). It delivers radiation directly to the bone tumors.

More information: Santanu Maji et al, MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis, Proceedings of the National Academy of Sciences (2023).